Comparative Efficacy and Safety of Weekly GLP-1/GIP Agonists vs. Weekly Insulin in Type 2 Diabetes: A Network Meta-Analysis of Randomized Controlled Trials
Abstract
Share and Cite
Ayesh, H.; Suhail, S.; Ayesh, S.; Niswender, K. Comparative Efficacy and Safety of Weekly GLP-1/GIP Agonists vs. Weekly Insulin in Type 2 Diabetes: A Network Meta-Analysis of Randomized Controlled Trials. Biomedicines 2024, 12, 1943. https://doi.org/10.3390/biomedicines12091943
Ayesh H, Suhail S, Ayesh S, Niswender K. Comparative Efficacy and Safety of Weekly GLP-1/GIP Agonists vs. Weekly Insulin in Type 2 Diabetes: A Network Meta-Analysis of Randomized Controlled Trials. Biomedicines. 2024; 12(9):1943. https://doi.org/10.3390/biomedicines12091943
Chicago/Turabian StyleAyesh, Hazem, Sajida Suhail, Suhail Ayesh, and Kevin Niswender. 2024. "Comparative Efficacy and Safety of Weekly GLP-1/GIP Agonists vs. Weekly Insulin in Type 2 Diabetes: A Network Meta-Analysis of Randomized Controlled Trials" Biomedicines 12, no. 9: 1943. https://doi.org/10.3390/biomedicines12091943